Key Takeaways
- • Glen Oaks Capital and Tecum Capital have jointly acquired StanChem, a combined platform of resin and coatings manufacturers headquartered in East Berlin, Connecticut, though deal valuation was not disclosed in available reporting.
- • The acquired platform integrates StanChem Resins and Dux Coatings, positioning the combined entity to serve customers across architectural, industrial, and specialty coatings markets.
- • The acquisition represents a consolidation strategy in the resins and coatings sector, combining complementary manufacturing operations under joint sponsor ownership.
Summary
Glen Oaks Capital and Tecum Capital have completed a joint acquisition of StanChem, a platform combining resin and coatings manufacturers StanChem Resins and Dux Coatings. The combined business is based in East Berlin, Connecticut, and operates across architectural, industrial, and specialty market segments within the coatings and resins industry.
The transaction structure reflects a typical sponsor consortium approach, with both Glen Oaks Capital and Tecum Capital taking equity stakes in the combined platform. This co-investment model allows the sponsors to pool capital and operational expertise while maintaining aligned interests in executing a value creation strategy across the combined business.
StanChem's operational footprint spans multiple customer verticals within the coatings ecosystem. The architectural segment serves building and construction applications, while the industrial division addresses manufacturing, industrial maintenance, and performance coatings demand. The specialty markets segment targets niche applications requiring customized resin and coating formulations. This diversified customer base provides revenue stability across economic cycles and end-market conditions.
Specific deal valuation, transaction multiples, financing structure, and detailed go-forward strategic plans were not disclosed in the announcement. The acquisition reflects ongoing consolidation activity in the specialty chemicals and coatings sector, where sponsor-backed platforms continue to pursue bolt-on acquisitions and operational improvements to drive return profiles.
The transaction structure reflects a typical sponsor consortium approach, with both Glen Oaks Capital and Tecum Capital taking equity stakes in the combined platform. This co-investment model allows the sponsors to pool capital and operational expertise while maintaining aligned interests in executing a value creation strategy across the combined business.
StanChem's operational footprint spans multiple customer verticals within the coatings ecosystem. The architectural segment serves building and construction applications, while the industrial division addresses manufacturing, industrial maintenance, and performance coatings demand. The specialty markets segment targets niche applications requiring customized resin and coating formulations. This diversified customer base provides revenue stability across economic cycles and end-market conditions.
Specific deal valuation, transaction multiples, financing structure, and detailed go-forward strategic plans were not disclosed in the announcement. The acquisition reflects ongoing consolidation activity in the specialty chemicals and coatings sector, where sponsor-backed platforms continue to pursue bolt-on acquisitions and operational improvements to drive return profiles.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.